Long-term treatment with phosphodiesterase type 5 inhibitor improves pulmonary hypertension caused by congestive heart failure through a natriuretic peptides-cGMP pathway

✍ Scribed by Takashi Yamamoto; Atsuyuki Wada; Masato Ohnishi; Takayoshi Tsutamoto; Masanori Fujii; Takehiro Matsumoto; Tomoyuki Takayama; Masahiko Kinoshita

• Book ID: 119544539
• Publisher: Elsevier Science
• Year: 2002
• Tongue: English
• Weight: 163 KB
• Volume: 39
• Category: Article
• ISSN: 1558-3597
• DOI: 10.1016/s0735-1097(02)80997-4